NLC2025 Info Site

KRASh Course on KRAS Non-G12C Mutated Lung Cancer

Friday, October 3, 2025

9:10 AM - 9:40 AM

Session Details

By the end of this session participants will be able to: 1. Review the challenges in developing targeted therapies for KRAS-mutated lung cancer 2. Describe advancements in the development of targeted therapies for KRAS mutated lung cancer outside of KRAS G12C 3. Discuss potential sequencing strategies and combination treatment for targeted therapy versus chemoimmunotherapy in KRAS non-G12C mutated lung cancer

You need to enable JavaScript to access this site.

Follow these instructions on how to enable JavaScript.

Internet Explorer

Select Tools from the top menu
Choose Internet Options
Click on the Security tab
Click on Custom Level
Scroll down until you see the section labelled Scripting
Under Active Scripting, select Enable and click OK

Google Chrome

Select the menu icon on the browser toolbar
Select Settings
Click the Show advanced settings... link then Content Settings in the Privacy section
Select Allow all sites to run JavaScript (recommended) and click Done

Safari (Mac)

Select Safari from the top menu
Choose Preferences
Choose Security
Select the checkbox next to Enable JavaScript